By proceeding, you agree to our Terms of Use and Privacy Policy.
Helping patients fight treatment resistant cancer. Resistance Bio can discover and overcome clinical treatment resistance pre-clinically.
22-24 February 2022
The Only Global RAS Dedicated Conference is Returning in 2022 with the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit! Year on year, we are proud to unite the leading frontiers of the RAS industry to showcase expertise, technical data and pipeli
Event Ended
Virtual
Paid
26-28 September 2022
For decades, RAS has existed as an elusive therapeutic target, and drugging this high-value oncogene was deemed impossible. Despite this, the first-ever FDA-approved KRAS G12C inhibitor has demonstrated that RAS is in fact druggable and that drugging
USA
Boston
11-11 October 2022
FOCUSED ON INNOVATION Explore cutting edge approaches with the potential to change how we view difficult-to-drug diseases. Bringing the leading experts across multiple disciplines together in one central hub, Next Generation Undruggable will explore
26-28 September 2023
5th Annual RAS-Targeted Drug Development SummitPersonalizing Medicine Via Targeting Oncogenic RAS for CancerWith the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable!